Pharmacokinetics and Safety Studies in Rodent Models Support Development of EPICERTIN as a Novel Topical Wound-Healing Biologic for Ulcerative Colitis.
Pharmacokinetics and Safety Studies in Rodent Models Support Development of EPICERTIN as a Novel Topical Wound-Healing Biologic for Ulcerative Colitis.
复制标题
啮齿动物模型中的药代动力学和安全性研究支持将 EPICERTIN 开发为治疗溃疡性结肠炎的新型外用伤口愈合生物制剂。
DOI：
10.1124/jpet.121.000904
复制
发表时间：
2022
期刊：
影响因子：
--
通讯作者：
Matoba,Nobuyuki
中科院分区：
文献类型：
--
作者：
Tusé,Daniel;Reeves,Micaela;Royal,Joshua;Hamorsky,KrystalT;Ng,Hanna;Arolfo,Maria;Green,Carol;Trigunaite,Abhishek;Parman,Toufan;Lee,Goo;Matoba,Nobuyuki
